iQure Pharma

Princeton, NJ · Founded 2019 · Privately Held (backing)

Developer of biopharmaceutical therapies designed to address central nervous system disorders by restoring glutamate homeostasis. iQure Pharma is based in Princeton, NJ and was founded in 2019. Its last reported valuation was $21 million in Nov 2025. It has raised $13.1 million across 4 recorded rounds; the latest was a $650,000 seed round in May 2026.

Last reported valuation
$21.0M
Oct 2026
Priced at
—
Total raised
$13.1M
Last round
Seed Round
May 2026
How much has iQure Pharma raised?
$13.1Macross 4 recorded rounds · Oct 2023 – May 2026

Most recently, iQure Pharma raised $650K in its Seed Round (May 2026).

Free account
More of iQure Pharma with a free account
  • ·Watch iQure Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

iQure Pharma round by round

4 rounds
May 2026Seed Round$650KSEC filing▮
1 investors participated
Sep 2025Seed Round$1.5MSEC filing▮
14 investors participated
Dec 2024Debt$1.4MSEC filing▮
2 investors participated
Oct 2023Seed Round$1.5MSEC filing▮
13 investors participated

How much has iQure Pharma raised?

iQure Pharma has raised $13.1 million in total; 4 of its rounds are on record, from 2023 on. The largest on record was a $650,000 seed round in May 2026.

iQure Pharma has filed 3 Form Ds with the SEC since 2023, most recently in Jan 2025 ($1.4 million sold to 2 investors).

iQure Pharma investors

8 investors are on record for iQure Pharma, including Keiretsu Forum, Endless Frontier Labs, SideCar Angels and Accelerator Venture Partners. The seed round in May 2026 drew 1 investor.

For fundraisers
Raising for a company like iQure Pharma?

8 investors have backed iQure Pharma.

See all 8 investors →

Frequently asked about iQure Pharma

How much has iQure Pharma raised?
iQure Pharma has raised $13.1M in total across 4 recorded funding rounds.
When was iQure Pharma's last funding round?
iQure Pharma's most recent recorded round was Seed Round in May 2026, raising $650K.